Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia:: 2004

被引:17
|
作者
Donegan, Elizabeth A.
Wirawan, Dewa N.
Muliawan, P.
Schachter, Julius
Moncada, Jeanne
Parekh, Manhar
Knapp, Joan S.
机构
[1] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA
[2] Kerti Praja Fdn, Bali, Indonesia
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1097/01.olq.0000216012.83990.bd
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: In the mid-1990s, fluoroquinolones were introduced in Indonesia for the management of gonorrhea and are now part of the national recommended treatment guidelines. We recently documented introduction of ciprofloxacin-resistant Neisseria gonorrhoeae strains in female sex workers (FSWs) in Timika, Indonesia, 5 years after treating gonococcal cervicitis with ciprolloxacin and periodically monitoring antimicrobial susceptibility of isolates. To assess the importance of this observation, we determined antimicrobial susceptibilities and strain types of N. gonorrhoeae isolates from FSWs seen in a sexually transmitted infection (STI) clinic in Denpasar, Bali, Indonesia. Goal: The goal of this study was to determine antimicrobial susceptibilities and strain types among N. gonorrhoeae isolated from FSWs in Denpasar, Bali. Study Design: FSWs in Denpasar were screened for N. gonorrhoeae by standard culture. Endocervicall isolates were frozen in Microbank tubes and sent to the University of California at San Francisco on dry ice. Antimicrobial susceptibility testing using a Clinical Laboratory Standards Institute-recommended agar dilution method was performed at the Centers for Disease Control and Prevention. Isolates were characterized by beta-lactamase production, antimicrobial resistance phenotypes, and auxotype/serovar class. Results: One hundred forty-seven N. gonorrhoeae isolates were characterized. All isolates were highly resistant to tetracycline (minimum inhibitory concentration, >= 16.0 mu g/mL): 117 (79.1%). were beta-lactamase-positive (PP-TR), 3 (2.0%) exhibited chromosomally mediated resistance to penicillin (PenR-TRNG), and 27 (18.2%) were susceptible to penicillin (TRNG). All isolates were susceptible to ceftriaxone, cefixime, and spectinomycin; lack of interpretive criteria do not allow interpretation of susceptibilities of cefoxitin, cefpodoxime, or azithromycin. Fifty-nine (40.1%) isolates were ciprofloxacin-resistant; 35 (59.3%) of the ciprofloxacin-resistant isolates exhibited high-level resistance to ciprofloxacin (Cip-HLR; minimum inhibitory concentration, >= 4.0 ug/mL of ciprofloxacin). Three (2.0%) isolates were intermediate to ciprofloxacin. Twenty-two strain types were identified among these isolates; small clusters were identified with 3 strain types. Conclusions: N. gonorrhoeae isolates from FSWs in Denpasar were resistant to penicillin and tetracycline; 40.1% of the isolates were fluoroquinolone-resistant. With gonorrhea prevalence of 35% at this clinic (by nucleic acid amplified tests), ongoing surveillance for antimicrobial resistance will be needed to appropriately choose treatment for infections caused by these resistant organisms.
引用
收藏
页码:625 / 629
页数:5
相关论文
共 50 条
  • [31] Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia
    Yanagi, Daisuke
    de Vries, Garry Cores
    Rahardjo, Dadik
    Alimsardjono, Lindawati
    Wasito, Eddy Bagus
    De, Ismoedijanto
    Kinoshita, Shouhiro
    Hayashi, Yoshitake
    Hotta, Hak
    Osawa, Ro
    Kawabata, Masato
    Shirakawa, Toshiro
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (04) : 422 - 426
  • [32] Rapid detection of GYRA and PARC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae urethritis by denaturing high-performance liquid chromatography (DHPLC)
    Shigemura, K
    Shirakawa, T
    Okada, H
    Tanaka, K
    Arakawa, S
    Kamidono, S
    Gotoh, A
    JOURNAL OF UROLOGY, 2004, 171 (04): : 31 - 31
  • [33] Fluoroquinolone-resistant Salmonella Paratyphi A
    Adachi, T
    Sagara, H
    Hirose, K
    Watanabe, H
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 172 - 174
  • [34] Fluoroquinolone-resistant Streptococcus pneumoniae
    Drlica, K
    Zhao, XL
    REVIEWS IN MEDICAL MICROBIOLOGY, 2003, 14 (03) : 95 - 103
  • [35] Fluoroquinolone-resistant Streptococcus pneumoniae
    Pletz, Mathias W. R.
    Fugit, Randolph V.
    McGee, Lesley
    Glasheen, Jeffery J.
    Keller, Darcie L.
    Welte, Tobias
    Klugman, Keith P.
    EMERGING INFECTIOUS DISEASES, 2006, 12 (09) : 1462 - 1463
  • [36] Increases in fluoroquinolone-resistant Neisseria gonorrhoeae -: Hawaii and California, 2001 (Reprinted from MMWR, vol 51, pg 1041-1044, 2002)
    Whiticar, PM
    Ohye, RG
    Lee, MV
    Bauer, HM
    Bolan, G
    Wang, SA
    Gunn, RA
    Weinstock, HS
    Berman, SM
    Mark, KE
    Newman, LM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23): : 2961 - 2963
  • [37] Fluoroquinolone-resistant gonorrhea increasing
    Fox, S
    INFECTIONS IN MEDICINE, 2003, 20 (01) : 48 - 48
  • [39] Fluoroquinolone-resistant Neisseria gonorrhoeae -: San Diego, California, 1997 (Reprinted from MMWR, vol 47, pg 405-408, 1998)
    Brazell, T
    Peter, C
    Ginsberg, M
    Montes, J
    Bolan, G
    Waterman, S
    Ehret, J
    Judson, FN
    ARCHIVES OF DERMATOLOGY, 1998, 134 (08) : 1049 - 1050
  • [40] Emergence of fluoroquinolone-resistant Neisseria meningitidis -: Minnesota and North Dakota, 2007-2008
    Takhar, Sukhjit S.
    Talan, David A.
    Moran, Gregory J.
    Pinner, Robert
    ANNALS OF EMERGENCY MEDICINE, 2008, 52 (03) : 286 - 288